Why AI’s Biggest Risk Isn’t Hallucination—It’s Unauthorized Execution

Telling an AI agent what not to do is different from designing a system that makes certain actions impossible.​​

A New Drug Takes Aim At One Of Cancer’s Most Difficult Targets

FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.

The Resume Mirage: How To Spot True Technical Competence In An Automated World

The automation of candidate applications is a genie that won’t go back into the bottle.

What Happens When A Small Business Quits Social Media

Quitting social media doesn’t have to cost you clients. How one small business grew without it — and what to build instead.

How To Quit Social Media Without Hurting Your Small Business

Quitting social media doesn’t have to cost you clients. How one small business grew without it — and what to build instead.

​Why Healthcare Needs An ‘Application Undertaker’

A dedicated person must establish the governance, operating discipline and accountability required to retire applications continuously as a regular discipline.

OpenAI Targets Junior Banker Work With ChatGPT For Financial Services

OpenAI launched ChatGPT for Financial Services with Morgan Stanley and Evercore, automating research and pitchbook work long done by junior bankers.

Here’s Why Sony And Hideo Kojima Divorced Over ‘Physint’

Sony and Hideo Kojima have separated and will no longer produce ‘Physint’ together, but it’s more complicated than just being a PR loss for PlayStation.

The Next AI Breakthrough Isn’t Smarter Models—It’s Something The Industry Forgot To Build

Addressing AI drift means developing a way for systems to understand how people are actually responding as an interaction unfolds.

AI As A Workforce Multiplier: The Next Frontier In Rural And Underserved Healthcare

The next chapter of healthcare AI should extend the reach of healthcare professionals to populations that have historically been underserved.